CGEM

Cullinan Oncology LLC is a dynamic biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on pioneering targeted oncology and immuno-oncology therapies to enhance outcomes for cancer patients. Committed to innovation and strategic partnerships, Cullinan is developing a diverse pipeline of therapeutic candidates that address significant unmet medical needs in the oncology sector. By harnessing state-of-the-art science and technology, the company aims to revolutionize cancer treatment options and establish itself as a key contributor in the rapidly evolving landscape of oncology therapeutics.